{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T12:14:45Z","timestamp":1789820085724,"version":"4.0.1"},"reference-count":62,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01HL126974"],"award-info":[{"award-number":["R01HL126974"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.jtha.2022.10.005","type":"journal-article","created":{"date-parts":[[2023,1,25]],"date-time":"2023-01-25T10:24:05Z","timestamp":1674642245000},"page":"467-479","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Tissue factor pathway inhibitor is a potential modifier of bleeding risk in factor XI deficiency"],"prefix":"10.1016","volume":"21","author":[{"given":"St\u00e9phanie E.","family":"Reitsma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lori A.","family":"Holle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma G.","family":"Bouck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dougald M.","family":"Monroe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan E.","family":"Mast","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Burthem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula H.B.","family":"Bolton-Maggs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gillian N.","family":"Gidley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alisa S.","family":"Wolberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2022.10.005_bib1","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.1538-7836.2009.03395.x","article-title":"Factor XI deficiency in humans","volume":"7","author":"Seligsohn","year":"2009","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2022.10.005_bib2","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1056\/NEJM199107183250303","article-title":"Factor XI deficiency in Ashkenazi Jews in Israel","volume":"325","author":"Asakai","year":"1991","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtha.2022.10.005_bib3","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1080\/17474086.2016.1191944","article-title":"Why factor XI deficiency is a clinical concern","volume":"9","author":"Wheeler","year":"2016","journal-title":"Expert Rev Hematol"},{"key":"10.1016\/j.jtha.2022.10.005_bib4","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1182\/blood.V51.6.1223.1223","article-title":"High gene frequency of factor XI (PTA) deficiency in Ashkenazi Jews","volume":"51","author":"Seligsohn","year":"1978","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2022.10.005_bib5","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/j.1365-2141.1988.tb02409.x","article-title":"Inheritance and bleeding in factor XI deficiency","volume":"69","author":"Bolton-Maggs","year":"1988","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtha.2022.10.005_bib6","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1182\/blood.V65.3.719.719","article-title":"Comparison of bleeding tendency, factor XI coagulant activity, and factor XI antigen in 25 factor XI-deficient kindreds","volume":"65","author":"Ragni","year":"1985","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2022.10.005_bib7","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1055\/s-0041-1735971","article-title":"The association between factor XI deficiency and the risk of bleeding, cardiovascular, and venous thromboembolic events","volume":"122","author":"Sharman Moser","year":"2022","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2022.10.005_bib8","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/hae.12628","article-title":"Bleeding phenotype and correlation with factor XI (FXI) activity in congenital FXI deficiency: results of a retrospective study from a single centre","volume":"21","author":"Santoro","year":"2015","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2022.10.005_bib9","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/hae.13112","article-title":"Evaluation of the use of global haemostasis assays to monitor treatment in factor XI deficiency","volume":"23","author":"Pike","year":"2017","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2022.10.005_bib10","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.thromres.2015.06.025","article-title":"The impact of thrombin generation and rotation thromboelastometry on assessment of severity of factor XI deficiency","volume":"136","author":"Livnat","year":"2015","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2022.10.005_bib11","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/hae.14506","article-title":"Report of surgeries, their outcome and the thrombin generation assay in patients with factor XI deficiency: a retrospective single-centre study","volume":"28","author":"Desage","year":"2022","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2022.10.005_bib12","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1182\/blood-2014-12-616565","article-title":"Sample conditions determine the ability of thrombin generation parameters to identify bleeding phenotype in FXI deficiency","volume":"126","author":"Pike","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2022.10.005_bib13","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1111\/j.1365-2516.2010.02246.x","article-title":"Thrombin generation in patients with factor XI deficiency and clinical bleeding risk","volume":"16","author":"Rugeri","year":"2010","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2022.10.005_bib14","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1111\/jth.12600","article-title":"Abnormal plasma clot structure and stability distinguish bleeding risk in patients with severe factor XI deficiency","volume":"12","author":"Zucker","year":"2014","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2022.10.005_bib15","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1182\/bloodadvances.2017015123","article-title":"Abnormal plasma clot formation and fibrinolysis reveal bleeding tendency in patients with partial factor XI deficiency","volume":"2","author":"Gidley","year":"2018","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2022.10.005_bib16","doi-asserted-by":"crossref","first-page":"2934","DOI":"10.1182\/blood-2013-11-512764","article-title":"Biology of tissue factor pathway inhibitor","volume":"123","author":"Wood","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2022.10.005_bib17","doi-asserted-by":"crossref","first-page":"17838","DOI":"10.1073\/pnas.1310444110","article-title":"Tissue factor pathway inhibitor-alpha inhibits prothrombinase during the initiation of blood coagulation","volume":"110","author":"Wood","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jtha.2022.10.005_bib18","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1182\/bloodadvances.2017011098","article-title":"TFPIalpha interacts with FVa and FXa to inhibit prothrombinase during the initiation of coagulation","volume":"1","author":"Wood","year":"2017","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2022.10.005_bib19","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1055\/s-0037-1615964","article-title":"The role of factor XI in thrombin generation induced by low concentrations of tissue factor","volume":"85","author":"Keularts","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2022.10.005_bib20","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1111\/jth.15716","article-title":"Revised model of the tissue factor pathway of thrombin generation: role of the feedback activation of FXI","volume":"20","author":"Lakshmanan","year":"2022","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2022.10.005_bib21","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1182\/blood.V86.8.3035.3035","article-title":"Feedback activation of factor XI by thrombin in plasma results in additional formation of thrombin that protects fibrin clots from fibrinolysis","volume":"86","author":"von dem Borne","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2022.10.005_bib22","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1182\/blood-2014-10-604587","article-title":"Activated factor XI increases the procoagulant activity of the extrinsic pathway by inactivating tissue factor pathway inhibitor","volume":"125","author":"Puy","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2022.10.005_bib23","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/ijlh.13155","article-title":"Investigation of patients with unclassified bleeding disorder and abnormal thrombin generation for physiological coagulation inhibitors reveals multiple abnormalities and a subset of patients with increased tissue factor pathway inhibitor activity","volume":"42","author":"MacDonald","year":"2020","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.jtha.2022.10.005_bib24","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1182\/bloodadvances.2020003464","article-title":"Elevated levels of tissue factor pathway inhibitor in patients with mild to moderate bleeding tendency","volume":"5","author":"Mehic","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2022.10.005_bib25","doi-asserted-by":"crossref","first-page":"3615","DOI":"10.1182\/blood-2008-06-162453","article-title":"Low plasma levels of tissue factor pathway inhibitor in patients with congenital factor V deficiency","volume":"112","author":"Duckers","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2022.10.005_bib26","doi-asserted-by":"crossref","first-page":"e151","DOI":"10.1016\/j.thromres.2012.05.010","article-title":"Studies on the mechanism of action of the aptamer BAX499, an inhibitor of tissue factor pathway inhibitor","volume":"130","author":"Chang","year":"2012","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2022.10.005_bib27","doi-asserted-by":"crossref","first-page":"16786","DOI":"10.1016\/S0021-9258(17)44829-0","article-title":"Recombinant human extrinsic pathway inhibitor. Production, isolation, and characterization of its inhibitory activity on tissue factor-initiated coagulation reactions","volume":"265","author":"Pedersen","year":"1990","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jtha.2022.10.005_bib28","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.thromres.2011.04.009","article-title":"Recombinant factor VIIa analog NN1731 (V158D\/E296V\/M298Q-FVIIa) enhances fibrin formation, structure and stability in lipidated hemophilic plasma","volume":"128","author":"Gray","year":"2011","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2022.10.005_bib29","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/rth2.12058","article-title":"Mast AE Correlates of plasma and platelet tissue factor pathway inhibitor, factor V, and protein S","volume":"2","author":"Ellery","year":"2018","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.jtha.2022.10.005_bib30","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1111\/jth.13342","article-title":"Reduced fibrinolytic resistance in patients with factor XI deficiency. Evidence of a thrombin-independent impairment of the thrombin-activatable fibrinolysis inhibitor pathway","volume":"14","author":"Colucci","year":"2016","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2022.10.005_bib31","doi-asserted-by":"crossref","first-page":"4378","DOI":"10.1074\/jbc.273.8.4378","article-title":"Regulation of extrinsic pathway factor Xa formation by tissue factor pathway inhibitor","volume":"273","author":"Baugh","year":"1998","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jtha.2022.10.005_bib32","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1182\/bloodadvances.2021004651","article-title":"Tissue factor pathway inhibitor and bleeding tendency: can hormonal state explain the differences?","volume":"5","author":"Dahm","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2022.10.005_bib33","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/(SICI)1096-8652(199903)60:3<175::AID-AJH1>3.0.CO;2-X","article-title":"Decreased plasma tissue factor pathway inhibitor in women taking combined oral contraceptives","volume":"60","author":"Harris","year":"1999","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jtha.2022.10.005_bib34","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1111\/hae.13860","article-title":"Measurement of plasma and platelet tissue factor pathway inhibitor, factor V and protein S in people with haemophilia","volume":"25","author":"Ellery","year":"2019","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2022.10.005_bib35","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/j.1365-2516.2010.02391.x","article-title":"Difference in TFPI levels between haemophilia A and B patients","volume":"17","author":"Tardy-Poncet","year":"2011","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2022.10.005_bib36","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/jth.15612","article-title":"Factor V east Texas variant causes bleeding in a three-generation family","volume":"20","author":"Peterson","year":"2022","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2022.10.005_bib37","doi-asserted-by":"crossref","first-page":"3777","DOI":"10.1172\/JCI69091","article-title":"Coagulation factor V(A2440G) causes east Texas bleeding disorder via TFPI\u03b1","volume":"123","author":"Vincent","year":"2013","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jtha.2022.10.005_bib38","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1111\/jth.15314","article-title":"F5-Atlanta: a novel mutation in F5 associated with enhanced East Texas splicing and FV-short production","volume":"19","author":"Zimowski","year":"2021","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2022.10.005_bib39","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1182\/blood-2014-08-592733","article-title":"A\u00a0novel mutation in the F5 gene (factor V Amsterdam) associated with bleeding independent of factor V procoagulant function","volume":"125","author":"Cunha","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2022.10.005_bib40","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1182\/blood.V90.3.1055","article-title":"A\u00a0comparison of murine and human factor XI","volume":"90","author":"Gailani","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2022.10.005_bib41","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1111\/jth.14243","article-title":"Factor XI promotes hemostasis in factor IX-deficient mice","volume":"16","author":"Mohammed","year":"2018","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2022.10.005_bib42","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/00001721-199703000-00008","article-title":"A\u00a0murine model of factor XI deficiency","volume":"8","author":"Gailani","year":"1997","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.jtha.2022.10.005_bib43","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1111\/jth.12188","article-title":"Comparison of the inhibitory activities of human tissue factor pathway inhibitor (TFPI)\u03b1 and TFPI\u03b2","volume":"11","author":"Maroney","year":"2013","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2022.10.005_bib44","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1016\/j.thromres.2010.01.038","article-title":"Alternatively spliced isoforms of tissue factor pathway inhibitor","volume":"125","author":"Maroney","year":"2010","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2022.10.005_bib45","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1111\/jth.14288","article-title":"Re-evaluation of mouse tissue factor pathway inhibitor and comparison of mouse and human tissue factor pathway inhibitor physiology","volume":"16","author":"Girard","year":"2018","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2022.10.005_bib46","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1182\/blood-2019-130360","article-title":"The tissue factor pathway inhibitor gamma knockout mouse is a better model than the wild type mouse for studying tissue factor-related human diseases","volume":"134","author":"Girard","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2022.10.005_bib47","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1111\/jth.14494","article-title":"A\u00a0non-circulating pool of factor XI associated with glycosaminoglycans in mice","volume":"17","author":"Mohammed","year":"2019","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2022.10.005_bib48","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1111\/j.1538-7836.2009.03454.x","article-title":"Temporal expression of alternatively spliced forms of tissue factor pathway inhibitor in mice","volume":"7","author":"Maroney","year":"2009","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2022.10.005_bib49","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1097\/00001721-199507000-00004","article-title":"Blocking of tissue factor pathway inhibitor (TFPI) shortens the bleeding time in rabbits with antibody induced haemophilia A","volume":"6","author":"Erhardtsen","year":"1995","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.jtha.2022.10.005_bib50","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/hae.13679","article-title":"Tissue factor pathway inhibitor is the main determinant of thrombin generation in haemophilic patients","volume":"25","author":"Chelle","year":"2019","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2022.10.005_bib51","doi-asserted-by":"crossref","first-page":"5871","DOI":"10.1182\/blood-2012-01-401620","article-title":"Hemostatic effect of a monoclonal antibody mAb 2021 blocking the interaction between FXa and TFPI in a rabbit hemophilia model","volume":"119","author":"Hilden","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2022.10.005_bib52","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1111\/j.1538-7836.2012.04790.x","article-title":"Inhibition of tissue factor pathway inhibitor by the aptamer BAX499 improves clotting of hemophilic blood and plasma","volume":"10","author":"Gorczyca","year":"2012","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2022.10.005_bib53","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1074\/jbc.M113.533836","article-title":"Small peptides blocking inhibition of factor Xa and tissue factor-factor VIIa by tissue factor pathway inhibitor (TFPI)","volume":"289","author":"Dockal","year":"2014","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jtha.2022.10.005_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcmd.2022.102663","article-title":"Anti-TFPI for hemostasis induction in patients with rare bleeding disorders, an ex\u00a0vivo thrombin generation (TG) guided pilot study","volume":"95","author":"Barg","year":"2022","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.jtha.2022.10.005_bib55","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41572-021-00278-x","volume":"7","author":"Berntorp","year":"2021","journal-title":"Haemophilia Nat Rev Dis Primers"},{"key":"10.1016\/j.jtha.2022.10.005_bib56","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1111\/jth.15697","article-title":"Regulation of coagulation by tissue factor pathway inhibitor: implications for hemophilia therapy","volume":"20","author":"Mast","year":"2022","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2022.10.005_bib57","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1365-2141.2011.08945.x","article-title":"Biological determinants of bleeding in patients with heterozygous factor XI deficiency","volume":"156","author":"Gu\u00e9guen","year":"2012","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtha.2022.10.005_bib58","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1055\/s-0038-1653750","article-title":"Definition of the bleeding tendency in factor XI-deficient kindreds\u2014a clinical and laboratory study","volume":"73","author":"Bolton-Maggs","year":"1995","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2022.10.005_bib59","doi-asserted-by":"crossref","first-page":"6963","DOI":"10.1182\/blood-2011-07-368811","article-title":"Polyphosphate is a cofactor for the activation of factor XI by thrombin","volume":"118","author":"Choi","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2022.10.005_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2022.101567","article-title":"Skeletal muscle myosin promotes coagulation by binding factor XI via its A3 domain and enhancing thrombin-induced factor XI activation","volume":"298","author":"Morla","year":"2022","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jtha.2022.10.005_bib61","doi-asserted-by":"crossref","first-page":"5157","DOI":"10.1182\/bloodadvances.2020002452","article-title":"Association of ABO blood group with bleeding severity in patients with bleeding of unknown cause","volume":"4","author":"Mehic","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2022.10.005_bib62","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/j.1538-7836.2009.03712.x","article-title":"Hereditary and acquired protein S deficiencies are associated with low TFPI levels in plasma","volume":"8","author":"Castoldi","year":"2010","journal-title":"J\u00a0Thromb Haemost"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622071744?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622071744?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T03:37:29Z","timestamp":1761536249000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622071744"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":62,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S1538783622071744"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2022.10.005","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tissue factor pathway inhibitor is a potential modifier of bleeding risk in factor XI deficiency","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2022.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}